Latest from Healthcare

Editorial: Still paying for bungled RATs rollout

The Government's delivery of RATs was flawed from the outset.

Jarden Brief: Meta on a Quest for new VR subscription service

VR attempt to curb the recent trajectory of multi-billion operating loss.

'Tour de force' in heritage restoration wins Property Council award

Sensitive refurbishment and amalgamation of the buildings takes prize.

Auckland airport share sale: Ratepayers could end up being short-changed

Council's compromise might have just delivered Aucklanders the worst of two worlds.

$166m expansion at Wellington's biggest private hospital

Full hospital redevelopment 5km south of the city's CBD.

Jarden Brief: Another chipmaker wants a slice of the hot stock action

Nasdaq and Dow Jones down as debt debate starts, but chipmaker upbeat.

Post-Covid reality check? F&P Healthcare profit drops 34pc

F&P Healthcare's earnings have fallen to more normal levels after a big Covid-surge.

Who’s in the running to handle possible Auckland Airport share sale?

Meanwhile, details emerge of Virgin Australia's re-listing plans.

Orion Health reveals measures to combat The Great Resignation

Snubbed at home, but contract wins offshore.

Covid-19 had a profound impact on F&P Healthcare, says CEO

Fisher & Paykel Healthcare's net profit dropped by 28 per cent to more normal levels.

F&P Healthcare net profit drops 28pc

The healthcare manufacturer withholds guidance for current year.

Result preview: What to expect from F&P Healthcare

F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.

NZ dollar falls to near two-year low as Wall St plunge drags shares down

A further plunge on Wall Street dragged the NZ sharemarket down nearly 1 per cent.

NZ shares finish flat but retail and Ryman stocks flourish

The New Zealand sharemarket finished the week on a subdued note.

Market close: Investors offload Ryman, F&P Healthcare shares

The New Zealand sharemarket opened the week with more than a 1 per cent fall.

F&P Healthcare share price drops after revenue guidance

The previous year's revenue came to $1.97b.